The Real Impact of Quality of Life (QOL) Endpoints on Market Access Decisions Across Markets – A Case Study Of Oncology Products
Abstract
Authors
R.B. Gardiner S. Sealey A. Edathodu S.R. Mukku
R.B. Gardiner S. Sealey A. Edathodu S.R. Mukku
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now